Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28,426 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vascular targeting of doxorubicin using cationic liposomes.
Wu J, Lee A, Lu Y, Lee RJ. Wu J, et al. Among authors: lu y. Int J Pharm. 2007 Jun 7;337(1-2):329-35. doi: 10.1016/j.ijpharm.2007.01.003. Epub 2007 Jan 9. Int J Pharm. 2007. PMID: 17275230
NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines.
Jaime-Ramirez AC, McMichael E, Kondadasula S, Skinner CC, Mundy-Bosse BL, Luedke E, Jones NB, Mani A, Roda J, Karpa V, Li H, Li J, Elavazhagan S, La Perle KM, Schmitt AC, Lu Y, Zhang X, Pan X, Mao H, Davis M, Jarjoura D, Butchar JP, Poi M, Phelps M, Tridandapani S, Byrd JC, Caligiuri MA, Lee RJ, Carson WE 3rd. Jaime-Ramirez AC, et al. Among authors: lu y. Cancer Immunol Res. 2016 Apr;4(4):323-336. doi: 10.1158/2326-6066.CIR-15-0168. Epub 2016 Feb 10. Cancer Immunol Res. 2016. PMID: 26865456 Free PMC article.
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells.
Gupta SV, Hertlein E, Lu Y, Sass EJ, Lapalombella R, Chen TL, Davis ME, Woyach JA, Lehman A, Jarjoura D, Byrd JC, Lucas DM. Gupta SV, et al. Among authors: lu y. Clin Cancer Res. 2013 May 1;19(9):2406-19. doi: 10.1158/1078-0432.CCR-12-2754. Epub 2013 Mar 20. Clin Cancer Res. 2013. PMID: 23515408 Free PMC article.
Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid.
Li H, Lu Y, Piao L, Wu J, Liu S, Marcucci G, Ratnam M, Lee RJ. Li H, et al. Among authors: lu y. Int J Pharm. 2010 Dec 15;402(1-2):57-63. doi: 10.1016/j.ijpharm.2010.09.019. Epub 2010 Sep 29. Int J Pharm. 2010. PMID: 20883757 Free PMC article.
Folate-immunoglobulin G as an anticancer therapeutic antibody.
Li H, Lu Y, Piao L, Wu J, Yang X, Kondadasula SV, Carson WE, Lee RJ. Li H, et al. Among authors: lu y. Bioconjug Chem. 2010 May 19;21(5):961-8. doi: 10.1021/bc900545h. Bioconjug Chem. 2010. PMID: 20429546 Free PMC article.
A liposomal delivery vehicle for the anticancer agent gossypol.
Zhai G, Wu J, Zhao X, Yu B, Li H, Lu Y, Ye W, Lin YC, Lee RJ. Zhai G, et al. Among authors: lu y. Anticancer Res. 2008 Sep-Oct;28(5A):2801-5. Anticancer Res. 2008. PMID: 19035313
Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
Xiang G, Wu J, Lu Y, Liu Z, Lee RJ. Xiang G, et al. Among authors: lu y. Int J Pharm. 2008 May 22;356(1-2):29-36. doi: 10.1016/j.ijpharm.2007.12.030. Epub 2007 Dec 28. Int J Pharm. 2008. PMID: 18258394 Free PMC article.
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ. Wu J, et al. Among authors: lu y. J Pharm Pharm Sci. 2007;10(3):350-7. J Pharm Pharm Sci. 2007. PMID: 17727798
Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells.
Lu Y, Wu J, Wu J, Gonit M, Yang X, Lee A, Xiang G, Li H, Liu S, Marcucci G, Ratnam M, Lee RJ. Lu Y, et al. Mol Pharm. 2007 Sep-Oct;4(5):707-12. doi: 10.1021/mp070058l. Epub 2007 Aug 21. Mol Pharm. 2007. PMID: 17708654
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825
28,426 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page